Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine HCG in Repeated Implantation Failure
NCT02870855Withdrawn
- Sponsor
- Reproductive and Genetic Hospital of CITIC-Xiangya
- Start
- Jul 2017
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human chorionic gonadotropin in infertility, sponsored by Reproductive and Genetic Hospital of CITIC-Xiangya. Primary endpoint: Clinical Pregnancy Rate at 28 days. Planned start Jul 2017; status: withdrawn.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02870855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02870855.